Bridgebio Pharma Inc

$11.70 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Bridgebio Pharma Inc

BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene therapy. The Company’s pipeline programs include product candidates ranging from early discovery to late-stage development. The Company’s products include BBP-561, BBP-711, BBP-631 and BBP-454.

Stock Analysis

last close $11.76
1-mo return -72.4%
3-mo return -75.4%
avg daily vol. 10.1M
52-week high 73.5
52-week low 11.2
market cap. $1.9B
forward pe -
annual div. -
roe -192.4%
ltg forecast -
dividend yield -
annual rev. $57M
inst own. 96%

Subscribe now for daily local and international financial news